Will the FDA Regulate Just Genetic Risk Data, or All Risk Data?
The latest in the 23andme versus FDA saga, in which the FDA halted 23andme from offering health-risk analyses of the genotyping service the company sells, comes...
Tag: 23andMe
23andMe Ceases Providing Health-Risk Info; Ancestry Only Now
The company announced today that in reaction to the FDA’s order to marketing health-related information based on its genetic testing, it will cease provid...
Is The National Cancer Institute Telling Me to Remove My Breasts?
One of the key issues in the dust-up over the FDA’s insistence on regulating 23andMe’s service is the question of how 23andMe’s health-risk r...
Biology/Biotech/Culture of Science/Genetics/Healthcare policy/History of science/Medicine/Uncategorized
I Got Your 23andMe – FDA Food Fight Links Right Here
Below find my ever-growing annotated collection of online responses to the FDA’s recent shot across the bow of 23andMe, the consumer genetics company. Unt...
What Does the FDA Want From 23andMe?
Here’s a particularly sharp, context-rich post on that question from from Margaret Curnutte, currently of Baylor University. It seems one of the more dee...
The F.D.A. Versus 23andMe: My New Yorker Piece
I’ve a piece up at The New Yorker on 23andMe’s clash with the FDA: Here’s the opening: The United States Food and Drug Administration is not k...
FDA Muzzles 23andMe After Talks Break Down
Note: If you’re here for the annotated links to other perspectives on the 23andMe/FDA dust-up, you should go instead to I Got Your 23andMe – FDA Food Figh...
The Case for Selective Paternalism in Genetic Testing
In the world of genetic testing, how much information is too much? Genetic counselor Laura Hercher argues that sometimes, selectivity is merited.
Embrace Your Dangerous Genome
Virginia Hughes is “sick of reading about the dangers of the genome.” So she complains over at Slate, eloquently, and I’m sick right with her....